ArticleCurrent oncology (Toronto, Ont.)2024

Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study.

Carlo Signorelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.